Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Rossi

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Blood Advances|November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter studyBruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Cancers|February 13, 2025
Long-Term Survival with Multiple Myeloma: An Italian ExperienceFrancesca Fazio, Martina Gherardini, Elena Rossi, et al.
Blood Advances|June 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with RuxolitinibFrancesca Palandri, Alessandra Dedola, Giovanni Caocci, et al.
Blood|April 23, 2021
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopeniaFrancesca Palandri, Elena Rossi, Daniela Bartoletti, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2025
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma PatientsSonia Morè, Massimo Offidani, Laura Corvatta, et al.
American Journal of Medical Genetics. Part A|July 21, 2004
Subtelomeric deletions of chromosome 9q: a novel microdeletion syndromeDouglas R Stewart, Alina Huang, Francesca Faravelli, et al.
American Journal of Hematology|June 15, 2024
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trialBianca Rocca, Alberto Tosetto, Giovanna Petrucci, et al.
Annals of Hematology|July 18, 2025
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study designValerio De Stefano, Francesco Passamonti, Francesca Palandri, et al.
Blood|April 9, 2020
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemiaBianca Rocca, Alberto Tosetto, Silvia Betti, et al.
Clinical Pharmacology and Therapeutics|November 7, 2021
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential ThrombocythemiaAlberto Tosetto, Bianca Rocca, Giovanna Petrucci, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Blood Advances|November 13, 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter studyBruno Fattizzo, Alfredo Marchetti, Alessandro Bosi, et al.
Cancers|February 13, 2025
Long-Term Survival with Multiple Myeloma: An Italian ExperienceFrancesca Fazio, Martina Gherardini, Elena Rossi, et al.
Blood Advances|June 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with RuxolitinibFrancesca Palandri, Alessandra Dedola, Giovanni Caocci, et al.
Blood|April 23, 2021
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopeniaFrancesca Palandri, Elena Rossi, Daniela Bartoletti, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2025
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma PatientsSonia Morè, Massimo Offidani, Laura Corvatta, et al.
American Journal of Medical Genetics. Part A|July 21, 2004
Subtelomeric deletions of chromosome 9q: a novel microdeletion syndromeDouglas R Stewart, Alina Huang, Francesca Faravelli, et al.
American Journal of Hematology|June 15, 2024
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trialBianca Rocca, Alberto Tosetto, Giovanna Petrucci, et al.
Annals of Hematology|July 18, 2025
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study designValerio De Stefano, Francesco Passamonti, Francesca Palandri, et al.
Blood|April 9, 2020
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemiaBianca Rocca, Alberto Tosetto, Silvia Betti, et al.
Clinical Pharmacology and Therapeutics|November 7, 2021
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential ThrombocythemiaAlberto Tosetto, Bianca Rocca, Giovanna Petrucci, et al.
Pageof 26